stars 1 stars 2 stars 3

Metrodora Therapeutics is dedicated to treating inflammation, infection and microbiome dysregulation. Our specialty focus thereby includes a commitment to serving the health and medical needs of people throughout their lives, and particularly so during vulnerable stages such as pregnancy, preterm birth and old age. Because the well-being of our patients is the core element of our mission, we consciously and routinely foster a patient-centric culture. Our culture is biased toward action, with an unbending commitment to service and excellence through innovation.

View Top Employees from Metrodora Therapeutics, Inc.

Metrodora Therapeutics, Inc. Questions

The Metrodora Therapeutics, Inc. annual revenue was $4 million in 2024.

Maura Matthews is the Vice President, Drug Development of Metrodora Therapeutics, Inc..

2 people are employed at Metrodora Therapeutics, Inc..

Metrodora Therapeutics, Inc. is based in Seattle, Washington.

The NAICS codes for Metrodora Therapeutics, Inc. are [54, 54171, 541, 541711, 5417].

The SIC codes for Metrodora Therapeutics, Inc. are [87, 873].

Top Metrodora Therapeutics, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users